About Us

Our Company

Neos Therapeutics develops, manufactures, and commercializes innovative extended-release (XR) products using our proprietary extended-release drug delivery and orally disintegrating tablet (ODT) technology platforms. We have three approved ADHD products, two of which use our ODT technology and one of which is an extended-release oral suspension. Our growing ADHD product portfolio puts Neos in a unique position to help meet the different needs of patients who struggle with ADHD.